BP’s Idexx Laboratories IDXX Stock Holding History

BP’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,105	Closed	-$1.33M	–	254
2021 Q2	$1.33M	Sell	2,105 -790	-27%	-$436K	0.06%	190
2021 Q1	$1.42M	Sell	2,895 -701	-19%	-$351K	0.05%	208
2020 Q4	$1.79M	Sell	3,596 -3,588	-50%	-$1.61M	0.05%	196
2020 Q3	$2.82M	Sell	7,184 -1,316	-15%	-$487K	0.07%	219
2020 Q2	$2.8M	Hold	8,500	–	–	0.1%	204
2020 Q1	$2.06M	Sell	8,500 -500	-6%	-$130K	0.09%	226
2019 Q4	$2.35M	Hold	9,000	–	–	0.08%	261
2019 Q3	$2.45M	Hold	9,000	–	–	0.09%	246
2019 Q2	$2.48M	Buy	9,000 +500	+6%	+$123K	0.09%	250
2019 Q1	$1.9M	Hold	8,500	–	–	0.07%	277
2018 Q4	$1.58M	Sell	8,500 -2,000	-19%	-$410K	0.07%	287
2018 Q3	$2.62M	Hold	10,500	–	–	0.08%	259
2018 Q2	$2.29M	Hold	10,500	–	–	0.07%	283
2018 Q1	$2.01M	Hold	10,500	–	–	0.07%	297
2017 Q4	$1.64M	Hold	10,500	–	–	0.06%	338
2017 Q3	$1.63M	Hold	10,500	–	–	0.06%	332
2017 Q2	$1.69M	Buy	+10,500	New	+$1.71M	0.06%	316

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BP's IDXX Position: Q3 2021 in Review

BP sold out of Idexx Laboratories (IDXX) in Q3 2021, closing a stake of 2,105 shares — an estimated $1.33M sold.

BP first reported a position in IDXX in Q2 2017 and held it in 17 quarters. The position peaked at $2.82M in Q3 2020. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

BP reported no remaining Idexx Laboratories position as of Q3 2021 after selling out during the quarter.
BP sold 2,105 Idexx Laboratories shares in Q3 2021, an estimated $1.33M.
BP first reported a position in Idexx Laboratories in Q2 2017 and held it in 17 quarters.
BP's Idexx Laboratories position peaked at $2.82M in Q3 2020.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.